Willis H. Gibbs v. HHS - Influenza, angioedema (2019)

Willis H. Gibbs filed a petition for compensation under the National Vaccine Injury Compensation Program on June 11, 2018, alleging he suffered angioedema as a result of an influenza vaccine administered on August 1, 2017.

Mr. Gibbs claimed the vaccine was administered in the United States and that he experienced residual effects of his condition for more than six months.

He also stated there had been no prior award or settlement of a civil action for damages related to his condition. The respondent, the Secretary of Health and Human Services, denied that the flu vaccine caused Mr.

Gibbs' alleged angioedema and residual effects, or any other injury. Despite this denial, on June 26, 2019, the parties filed a joint stipulation agreeing to settle the case.

Chief Special Master Nora Beth Dorsey reviewed the stipulation and adopted it as the decision of the Court. Pursuant to the stipulation, Mr.

Gibbs was awarded a lump sum of $105,000.00, payable to him, as compensation for all items of damages available under the Vaccine Act. The decision was entered on September 11, 2019.

Petitioner was represented by Nancy Routh Meyers of Ward Black Law, and respondent was represented by Voris Edward Johnson of the U.S. Department of Justice.

The public decision does not describe the onset of symptoms, specific clinical details, diagnostic tests, or treatments. The flu vaccine is listed on the Vaccine Injury Table.